On December 22, 2016, the LLC “Velfarm” (the Borrower of the Industrial Development Fund – IDF) has established an import-substituting medicine production, that conforms to GMP international standards. The total cost of the project is 1.1 billion rubles, of which IDF loan amounted to 500 million rubles.
The company’s range of products consists of more than 60 drugs, 37 of which are import-substituting. The annual capacity of the plant is 2.5 million packages of capsules, 4.5 million packages of injectable solutions, 15 million packages of drugs in powder form, 20 million tubes of ointments and gels, 35 million tablets with, or without coating.
Drugs are intended for the treatment of endocrine diseases, especially diabetes, gastrointestinal tract, cardiovascular system, epilepsy, Parkinson’s disease, allergies, dermatological disorders, etc.
Part of the production will be exported to Belarus, Kazakhstan, Vietnam, Mongolia, Moldova, Georgia, Armenia, Azerbaijan, Kyrgyzstan, Uzbekistan, Tajikistan, Afghanistan.
IDF funds were used by the borrower for the purchase of equipment, design, installation and commissioning of the high-tech clean room of area 1.2 thousand square meters. The clean room has regulated humidity, pressure, temperature, and the content of airborne microorganisms, dust, and other unwanted particles.
Including the project of “Velfarm” company, the total number of projects from the Kurgan region, that were co-financed by IDF, was 1.2 billion rubles, 550 million of which was the loan from IDF.
Since 2015, the Industrial Development Fund co-financed 111 projects in 42 regions in Russia for a total loan amount of 31.1 billion rubles. Implementation of the projects will bring 95.4 billion rubles in the real economy in addition to the IDF loan, and create almost 11,300 jobs. The total cost of the projects is 126.5 billion rubles.